The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Initiation and adherence with bone-targeting agents in US men with bone metastases from prostate cancer.
 
Alexander Liede
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Anne M. Butler
Research Funding - Amgen
 
Karynsa Cetin
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Rohini K Hernandez
Employment - Amgen
Stock and Other Ownership Interests - Amgen
 
Robert Overman
Employment - Cleveland Clinic; RxAnte
Research Funding - Amgen
 
JungIn Kim
Research Funding - Amgen
 
B. Diane Reams
Research Funding - Amgen
 
Bradford Richard Hirsch
Employment - Flatiron Health
Leadership - SignalPath Research
Stock and Other Ownership Interests - SignalPath Research
Consulting or Advisory Role - Astellas Pharma; Hospira; Pfizer; Sandoz
Research Funding - Astellas Pharma; Bristol-Myers Squibb; Dendreon; GlaxoSmithKline; Pfizer; Sanofi
Travel, Accommodations, Expenses - Astellas Pharma; Pfizer
 
Amy Pickar Abernethy
Employment - Flatiron Health
Leadership - Athenahealth
Stock and Other Ownership Interests - AthenaHealth; Flatiron Health; Orange Leaf Associates
Consulting or Advisory Role - Bristol-Myers Squibb; Helsinn Therapeutics
Research Funding - Bristol-Myers Squibb (Inst); Celgene (Inst); DARA BioSciences (Inst); Dendreon (Inst); GlaxoSmithKline (Inst); Helsinn Therapeutics (Inst); Pfizer (Inst)
 
M. Alan Brookhart
Honoraria - Amgen; GlaxoSmithKline; Merck
Consulting or Advisory Role - RxAnte; World Health Information Science Consultants
Research Funding - Amgen; AstraZeneca